Affordable Access

Publisher Website

Phase I studies with carboplatin at the Royal Marsden Hospital

Authors
Journal
Cancer Treatment Reviews
0305-7372
Publisher
Elsevier
Publication Date
Volume
12
Identifiers
DOI: 10.1016/0305-7372(85)90018-0
Disciplines
  • Pharmacology

Abstract

Abstract Carboplatin was evaluated in a Phase I and pharmacokinetic study at the Royal Marsden Hospital between April 1981 and November 1981. Sixty patients were entered of whom 16 had impaired renal function. No evidence of ototoxicity or nephrotoxicity was found. Nausea and vomiting were much reduced compared to cisplatin. The dose limiting toxicity was delayed myelosuppression with thrombocytopenia being more severe than leucopenia. A number of clinical responses were seen, particularly in patients with ovarian carcinoma. Pharmacokinetic studies suggested that the dose of JM8 should be adjusted according to the glomerular filtration rate.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Phase I studies with carboplatin at the Royal Mars...

on Cancer Treatment Reviews September 1985

Carboplatin in small cell lung cancer: the Royal M...

on Seminars in Oncology February 1992

Carboplatin in small cell lung cancer: The Royal M...

on Seminars in Oncology Jan 01, 1992

The Royal Marsden Hospital. Developing a curriculu...

on Nursing standard (Royal Colleg... 1990
More articles like this..